|
Recommended
|
June 23 - 26
San Diego
________________
|
|
Cut Cost of Doing Business
| |
Join the SoCalBio Group Purchasing Program to enjoy significant savings on office supplies from
Click here to learn more
For more info, call SoCalBio at
800-418-7079 ext 3
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
|
Register Now
| |
Join us for the SoCalBio Business Mixer focusing on
Big Healthcare Data & Analytics Innovations
February 27, 4:00 to 7:00 pm
@ Conference Room of the UCLA California Nanosystems Institute
Abstract This industry mixer will deal with the issues of managing massive healthcare data and commercial efforts made to develop the necessary predictive analytics and other tools to help physicians make clinical decisions based on such data. The event will feature a panel including local companies such as Medtronics and Boston Scientific Neuromodulation, practicing physicians, digital health companies such as TrendShift, and investors such as Poliwogg to discuss the following: - The promise of big data management in radicalizing patient care
- Is this promise overblown out of proportions and will Obamacare help?
- What is missing technologically to translate that promise into reality
- Commercial efforts done to manage, mine and monetize big data
- Local big data innovations and start-ups based on them
- Will big data provide another bioscience industry growth driver in Greater Los Angeles?
- Funding and nurturing the big data management eco-system
Speakers - Joseph Boystak, Partner, Poliwogg
- John Mastrototaro, Ph.D.,VP, Informatics, Medtronic, Inc.
- Robert Murtfeldt, VP of Business Development, Johnson & Johnson Diabetes
- Christopher Ritchie, President, TrendShift LLC
- Dennis Zottola, Director, Systems and Software, Boston Scientific Neuromodulation
Sponsors
|
|
Make Your Voice Heard in DC
|
Join SoCalBio at the BIO Legislative Day in Washington, D.C. on April 8 and 9
Join SoCalBio's team and other biotechnology executives from across the country who will go to D.C. for a day and a half of legislative briefings and advocacy on Capitol Hill. This fly-in is organized by the Biotechnology Industry Organization to give you the opportunity to meet with your congressional representative and other legislators to educate them about the importance of the biotech industry for job and wealth creation.
Contact SoCalBio, if you are a bioscience industry executive interested in participation and located in Los Angeles, Orange County, the Inland Empire and the communities of the Gold Coast of Ventura and Santa Barbara. Send email to: scbc@socalbio.org
|
| Meet New SoCalBio Members |
Biotechnical Services Inc. (San Diego)
Provides scientific lab equipment sales and services, such as calibration and validation.... Learn more
Response Genetics (Los Angeles)
Response Genetics is a publicly traded biotech company focused on developing molecular diagnostic assays to help determine the patient's response to cancer therapies ... Learn More
Pharmacos Biopharmaceutical Services (Irvine)
Pharmacos services small to mid-size specialty biopharmaceutical and medical device companies by providing a complete suite of outsourcing and/or consulting services which support drug development, registration, commercialization, life cycle management and commercial operations ..
Learn More
CRB USA (Carlsbad)
CRB is a global design, construction and consulting firm that services the bioscience and other advanced technology industries. The firm employs over 600 people in 10 offices serving clients throughout the world ... Learn More
|
|
Recommended Event
| |
Celebrate Medical Innovation at LA BioMed
Thursday, April 24, 2014 from -- 12:30 PM to 5:30 PM
Free for SoCalBio Members
|
|
Trends
|
75% of the World's Pharmaceutical R&D Spending Takes Place in the United States
Will This Dominance Continue?
 The Pharmaceutical Manufacturing Association's 2013 found U.S. drug makers are responsible for 75% of the world's pharmaceutical R&D spending. The report concludes that "this commitment (to R&D) is reflected in the many advances that we have already seen across a wide spectrum of diseases that affect millions. And it brings many benefits such as good jobs and economic investment to communities and states across the nation. The future holds great promise for continued advancements, and with sustained support for innovation, the U.S. biopharmaceutical sector will continue to lead the world" ... Read PHRMA's Report
|
| Drug Delivery |
UCLA Develops Contact Lens Using a Nanodiamond Gel to Deliver Glaucoma Drugs
 Using one of nature's simplest structures--the diamond--Dr Dean Ho (photo right) at the UCLA School of Dentistry leads a research effort to develop a nanogel that can be embedded into contact lenses, with the ultimate goal of delivering glaucoma drugs to the eye over an extended period of time. The new technology showed great promise for sustained glaucoma treatment and, as a side benefit, the nanodiamond-drug compound even improved the contact lenses' durability.... Read more
|
| Analysis |
Los Angeles' Two Young 'Cats' Of Biotech Poised To Climb Higher In 2014
 Seeking Alpha blogger -- Glenn Woods -- writes a commentary on the progress of the Los Angeles based Puma Biotechnology led by Alan Auerbach (photo right) and Lion Biotechnologies led by Manish Singh, PhD (photo right). He commented "besides being named after big cats, both companies focus on novel cancer treatments by licensing innovative drug candidates that are undergoing or have already been in clinical trials, then further develop these drugs for commercial use. Also both are young development stage companies with  CEOs that have excellent track records of building a small company into market capitalizations worth hundreds of millions of dollars. And if last year is any indication of what to expect in 2014, both companies may well continue to see their stocks rise significantly this year" ... Read more
|
| Grants |
West Los Angeles-Based NeuroSigma Wins a $313k SBIR Grant from the NIH
 On Feb 14, the National Institute of Neurological Disorders and Stroke awarded the UCLA-spinoff NeuroSigma an SBIR grant totaling $$313,545. The company's grant proposal states that "the purpose of this SBIR translational research project is to develop an implantable subcutaneous Trigeminal Nerve Stimulation System (sTNSTM) for the treatment of drug-resistant epilepsy." NeuroSigma plans to collaborate with the Minnesota-based Stellar Technologies to modify an existing multichannel implantable pulse generator to meet NeuroSigma's unique design specifications for sTNS... Learn More About NeuroSigma
|
| Public Offering |
Pasadena-Based Arrowhead Research Plans to Raise $104 Million in a Public Offering
 "Arrowhead intends to use the net proceeds from this offering for general corporate purposes, including working capital, capital expenditures, research and development expenditures and clinical trial expenditures. A portion of the net proceeds may also be used for the acquisition of complementary businesses, products and technologies, or for other strategic purposes" ... Read Press Release
|
| Collaboration |
Irvine-Based Allergan Signs a Retinal Disease R&D Partnership With Utah-Based Voyant Biotherapeutics
 "We look forward to a productive collaboration with Voyant to identify and develop novel therapies for retinal disease. This agreement highlights Allergan's commitment to academic and corporate partnerships to increase long-term innovation," said Scott Whitcup (photo right) CSO and EVP of R&D at Allergan... Read Press Release
|
| Jobs ... Jobs ... jobs |
Chromologic (Pasadena)
- Senior Hardware Engineer - Machine Vision Systems
- Sr. Scientist - Optics
- Sr. Scientist - Biomedical Engineering
- Senior Applications Engineer
- Senior Applications Engineer - Biomedical
- Principal Research Scientist - Biologics
Gilead (San Dimas)
Gilead (Oceanside)
Biolase (Irvine)
Xencor (Monrovia)
Aubery Group (Irvine)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
| Join SoCalBio | |
|
|
|
